HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael R Palmer Selected Research

Angiomyolipoma

12/2015Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael R Palmer Research Topics

Disease

3Neoplasms (Cancer)
12/2015 - 11/2013
2Tuberous Sclerosis (Bourneville's Disease)
12/2015 - 05/2015
1Angiomyolipoma
12/2015
1Hepatocellular Carcinoma (Hepatoma)
05/2015
1Breast Neoplasms (Breast Cancer)
11/2013

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
12/2015 - 11/2013
2EverolimusFDA Link
12/2015 - 05/2015
2trans-sodium crocetinate (crocetin)IBA
12/2015 - 05/2015
1TOR Serine-Threonine KinasesIBA
12/2015
1Mechanistic Target of Rapamycin Complex 1IBA
05/2015
1ParaffinIBA
11/2013
1SteroidsIBA
11/2013
1Biomarkers (Surrogate Marker)IBA
11/2013
1Formaldehyde (Formol)FDA Link
11/2013
1Hormones (Hormone)IBA
11/2013

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2013